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Plant-endophytes interaction 
influences the secondary 
metabolism in Echinacea purpurea 
(L.) Moench: an in vitro model
Valentina Maggini  1,2,3, Marinella De Leo4, Alessio Mengoni  1, Eugenia Rosaria Gallo2,3, 
Elisangela Miceli1, Rose Vanessa Bandeira Reidel4, Sauro Biffi5, Luisa Pistelli4, Renato Fani1, 
Fabio Firenzuoli3 & Patrizia Bogani1
The influence of the interaction(s) between the medicinal plant Echinacea purpurea (L.) Moench and 
its endophytic communities on the production of alkamides is investigated. To mimic the in vivo 
conditions, we have set up an infection model of axenic in vitro E. purpurea plants inoculated with 
a pool of bacterial strains isolated from the E. purpurea stems and leaves. Here we show different 
alkamide levels between control (not-inoculated) and inoculated plants, suggesting that the alkamide 
biosynthesis may be modulated by the bacterial infection. Then, we have analysed the branched-chain 
amino acids (BCCA) decarboxylase gene (GenBank Accession #LT593930; the enzymatic source for the 
amine moiety formation of the alkamides) expression patterns. The expression profile shows a higher 
expression level in the inoculated E. purpurea tissues than in the control ones. These results suggest that 
the plant-endophyte interaction can influence plant secondary metabolism affecting the therapeutic 
properties of E. purpurea.
Echinacea purpurea (L.) Moench (Asteraceae) is a medicinal plant with immune-modulatory and 
anti-inflammatory properties, whose roots and aerial parts are frequently used in Europe and North America 
for the preparation of therapeutic extracts for common cold1. It is rich in various phytochemicals including 
caffeic acid derivatives, alkamides and polysaccharides2. The concentrations of these bioactive compounds are 
species-specific and they may vary due to several factors such as plant material, cultivation techniques, plant 
tissue treatment, extraction methods and phytosanitary status3. Recently, the attention has been focused on the 
plant microbiota and its role in the production of secondary metabolites4,5. Many studies aim to investigate the 
influence of endophytic fungi on the production of plant bioactive molecules6,7 but the interest for the bacterial 
endophytes is considerably increasing8. Genomics and proteomics approaches have been applied to deepen the 
understanding of the plant-endophyte interaction9. Differential protein accumulations have been revealed in 
the proteome of in vitro-grown Zea mays10 and Chinese hybrid poplar clone 74111 inoculated or not-inoculated 
with Herbaspirillum seropedicae and Paenibacillus sp., respectively. In particular, the role of the endophytes is 
investigated related to agricultural aspects (e.g. plant-growth promoting and biocontrol) and very few studies 
have been conducted on medicinal plants3,12. E. purpurea root extracts are reported to stimulate macrophage 
TNF-α production but the extracts obtained from in vitro-grown axenic E. purpurea do not induce the same 
result, supporting the hypothesis that it is originated from the interaction with bacterial endophytes12. Our pre-
vious study shows that different compartments of E. purpurea, namely stems and leaves (SL), roots (R) and the 
rhizosphere (RS), share very few strains13. This finding has been shown to be related to the antagonism existing 
between strains inhabiting the different compartments14 and to the degree of resistance to antibiotics15. Moreover, 
the presence of distinct bacterial communities in plant compartments could account for the different bioactive 
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compounds found in the various plant organs. Therefore, E. purpurea represents an interesting and useful in vitro 
model for plant-bacterial interaction studies on the production of pharmacological relevant secondary metabo-
lites as the alkamides.
Alkamides (alkylamides; fatty acid amides) are lipophilic compounds chemically composed of two moie-
ties, an amine moiety acylated by a fatty acid-derived one16. They are important bioactive compounds dissimi-
larly distributed in the different compartments of E. purpurea17. Indeed, a notable difference is reported for the 
total alkamide content between aerial parts and roots, which is mainly due to a larger presence of non-tetraene 
alkamides in roots than in other plant organs18. The main Echinacea spp. alkamides are the isomeric dodeca-2E, 
4E, 8Z, 10E/Z-tetraenoic acid isobutylamides19. These compounds increase the TNF mRNA expression in 
macrophages and monocytes binding the cannabinoid CB2 receptor20. Furthermore, the alkylamides decrease 
mitogens-induced interleukin-2 secretion in Jurkat-T cells21 and show an in vitro inhibitory activity of the 
5-lipoxygenase22 and the cyclooxygenase-1 and 2 enzymes23.
Recently, a pyridoxal phosphate-dependent (PLP) decarboxylating enzyme belonging to the Class II trypto-
phan synthase family that utilizes branched-chain amino acids (BCAA) as substrate has been suggested24. Isotope 
labelling analyses have revealed the generation of isobutylamine and 2-methylbutylamine (i.e. the amine moiety 
of the E. purpurea alkamides) from valine and isoleucine, respectively. PLP decarboxylase-like proteins have been 
identified in the proteome of E. purpurea through in silico analyses and their transcript levels correlated with 
alkamide accumulation patterns in E. purpurea tissues. Then, a valine decarboxylase (VDC), potentially involved 
in the generation of the amine moieties of the alkamides, has been identified.
The aim of this work is to check the involvement of the endophytic communities of E. purpurea plants in 
the regulation of bioactive compound (alkamide) accumulation. To this purpose, we set up an in vitro model 
system in which axenic E. purpurea plants, in vitro germinated from sterilized seeds, are inoculated with a pool 
of selected endophytes previously isolated from the aerial compartment of E. purpurea plants cultivated in open 
field (Fig. 1). We have evaluated the biochemical alkamide profiles estimating different alkamide levels in control 
(not-inoculated) and inoculated plants. We have also found that the level of VDC gene expression is higher in the 
inoculated E. purpurea tissues than in the control ones, establishing a close relationship between the endophyte 
presence and alkamide levels.
Results
Bacterial endophytes tend to re-colonize the native niche during plant infection. A pool of 
thirty-seven bacterial strains (Supplementary Table 1), isolated from the SL compartment of E. purpurea plants, 
was used to inoculate five axenic in vitro 2-months old E. purpurea plants each with 6 or 7 leaflets; five plants 
of the same age, used as control, were inoculated with sterilized saline solution. The infection experiment was 
repeated three times. Forty-five days after the infection, plants were analysed for bacterial colonization estimating 
Figure 1. In vitro model system setting up to study the interaction between Echinacea purpurea plants and 
their stem/leaves endophytic bacteria. (A) Bacterial endophytes were isolated from the aerial compartment of 
E. purpurea plants. (B) E. purpurea seeds were provided by the common garden at the “Il Giardino delle Erbe”, 
Casola Valsenio, Italy and surface-sterilized. (C) Seeds were germinated in De Wit Culture tubes containing 5 ml 
of Linsmaier & Skoog Medium (LS) including vitamins. After root formation, the seedlings were transferred in 
Wavin flasks containing 50 ml of LS solid medium, supplemented with 3% sucrose and maintained in a plant 
growth chamber for a photoperiod of 16 h light a day. (D,E) After about 2 months, five E. purpurea plants were 
inoculated with 8 × 106 bacterial endophytes isolated from SL compartment of E. purpurea plants (D); five 
plants were used as control and were inoculated with sterilized saline solution (E). After 45 days, SL and root 
(R) samples from control and infected plants, were collected separately and sterilized. (F–H) Samples were then, 
separated in different aliquots (R and SL pooled separately). (I) One aliquot of each tissue was immediately used 
for the in planta bacterial growth analysis. (L) One aliquot of each tissue was weighed and dried at 60 °C to be 
used for n-hexane extracts preparation. (M) One aliquot of each tissue was ground to a fine powder in liquid 
nitrogen and successively used for RNA extraction.
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the total viable count (TVC) as Colony Forming Units (CFU)/g into the host R and SL tissues. Data obtained 
revealed that the highest CFU/g was detected in the SL compartment (7.06 ± 6.50 log CFU/g), and the lowest one 
in the roots of infected plants (6.70 ± 5.82 log CFU/g; P < 0.001). This finding could indicate that the endophytes 
tended to re-colonize the native niche (SL compartment). The absence of bacteria in the control plant tissues and 
in the washing solutions confirmed the use of an axenic plant model and a successful sterilization procedure, 
respectively.
Alkamide profiling analysis in different organs of control and infected plants. The alkamide pro-
files of both control and infected R and SL extracts of E. purpurea pooled plants were investigated by means of 
high performance liquid chromatography (HPLC) coupled to a photo diode array (PDA)/ultraviolet (UV) detec-
tor and electrospray ionization tandem mass spectrometry (ESI-MS/MS). The LC-PDA/UV chromatograms of 
both E. purpurea R and SL extracts showed different alkamide profiles (Supplementary Figs 1 and 2). In particu-
lar, the SL extracts appeared to be richer in alkamide content, with twelve identified compounds (1-12, Table 1), 
respect to the R samples (compounds 5, 7-12, Table 1) even though for the peaks A, B, G, K, and O two isomers 
can occur and their exact identification was not possible based on MS fragmentation pathway. Some alkamides 
present in the SL extract (peaks A, B, C, E, F, H, I, and M) were not found in the R one. On the other hand, two 
R extracts showed the presence of the alkamides 13/14 (peak O) and 15 (peak P), which were absent in the SL 
ones. In all R and SL samples, the most representative alkamides were a mixture of the two co-eluting isomers 
dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (7) and dodeca-2E,4E,8Z,10E tetraenoic acid isobutylamide 
(8). During the alkamide chromatography of both R and SL extracts, polyacetylene amides (peaks A, B, D, O, 
and P) elute early, followed by tetraenes (peaks G and K), trienes (peak L), and finally dienes (N). Interestingly, 
the analysis of the alkamide content in the E. purpurea plant organs also revealed the presence of seven alkamides 
not previously reported (peaks C, E, F, H, I, J, and M), but ascribable to the alkamide class due to the character-
istic absorbance at 260 nm and typical ESI-MS and MS/MS spectra (Supplementary Table 3). A tentative level 
estimation of the main alkamides was performed on control and infected R and SL extracts by measuring the 
peaks area and calculating the mean of the replicates (Supplementary Table 4). Data were submitted to Principal 
Component Analysis (PCA), and the result was reported in Fig. 2: the vectors accounting for the R extracts were 
differentially oriented than those of the SL ones (F = 10.42; P < 0.001). In particular, the R samples presented C12 
diene-diyne alkamides (peak O and P), whilst the SL samples contained C11 diene-diyne alkamides (peak A and 
B). Both samples showed a prevalence of C12 tetraene alkamides (peak G and K). Furthermore, PCA showed a 
discrimination among control and infected samples both for R and SL extracts and suggested that such differences 
were mainly created by the amount of the most abundant alkamide isomers 7 and 8 (peak G). The comparison 
of means (Supplementary Table 4) revealed that the amount of these alkamide isomers was significantly differ-
ent for all samples (Tukey HSD P < 0.001). A relative estimation of the alkamide isomers 7 and 8 in the R and 
SL infected samples was also performed in respect to the levels of the relative control samples showing that the 
infection resulted in an increase of alkamide levels of about 70% in SL and 87% in R infected samples compared 
to the controls.
BCCA decarboxylases genetic expression in different organs of control and infected plants. The 
relative quantification of VDC gene expression in the SL and R tissues of the control and infected E. purpurea plants was 
calculated in respect to the ubiquitin E2 (UbE2) gene expression in the three biological replicates. The amplification 
efficiency was optimal as achievable by the R2 and slope values (slopeVDC = –3.113; R2VDC = 0.904; slopeUbE2 = –3.182; 
Compound Peaka Organ Alkamides
1 A SL undeca-2E,4Z-diene-8,10-diynoic acid isobutylamide
2 A SL undeca-2Z,4E-diene-8,10-diynoic acid isobutylamide
3 B SL undeca-2E,4Z-diene-8,10-diynoic acid methylbutylamide
4 B SL undeca-2Z,4E-diene-8,10-diynoic acid methylbutylamide
5 D R, SL trideca-2E,7Z-diene-8,10-diynoic acid isobutylamide
6 D SL dodeca-2E,4Z,10E-triene-8-ynoic acid isobutylamide
7 G R, SL dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide
8 G R, SL dodeca-2E,4E,8Z,10E tetraenoic acid isobutylamide
9 K R, SL dodeca-2E,4E,8Z,10Z-tetraenoic acid methylbutylamide
10 K R, SL dodeca-2E,4E,8Z,10E-tetraenoic acid methylbutylamide
11 L R, SL dodeca-2E,4E,8Z-trienoic acid isobutylamide
12 N R, SL dodeca-2E,4E-dienoic acid isobutylamide
13 O R dodeca-2E,4Z-diene-8,10-diynoic acid isobutylbutylamide
14 O R dodeca-2Z,4E-diene-8,10-diynoic acid isobutylbutylamide
15 P R dodeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide
Table 1. Identification of alkamides detected in roots (R) and stem/leaves (SL) of control and infected E. 
purpurea plants. Compound numbers are referred to peaks in the chromatograms of Supplementary Figs 1 and 
2. Peaks C, E, F, H, I, J, and M remained unidentified. aTwo alkamide isomers are present under the same peak: 
A (1, 2), B (3, 4), G (7, 8), K (9, 10), and O (13, 14). The peak D is generated by the coelution of two not isomer 
alkamides (5, 6). The E/Z stereochemistry is indicated in accordance with the literature3,26–28.
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R2UbE2 = 0.988). As depicted in Fig. 3a, the VDC gene expression levels were higher in the SL samples than the R ones 
(P < 0.01). The VDC transcription level in the infected SL samples was about 4 times more than in the SL control 
tissues (P < 0.001). Also, the expression level resulted increased in R infected tissues respect to the relative controls 
even if at a minor extent (P < 0.01). In parallel, the involvement of an enzyme (serine decarboxylase SDC, GenBank 
Accession #LT593931.1) not decarboxylating valine or isoleucine (to form isobutylamine or 2-methylbutylamine, the 
amine moieties of the E. purpurea alkamides) but utilizing the serine as substrate to generate ethanolamine24 was eval-
uated. The transcription of the SDC gene (slopeSDC = −3.135; R2SDC = 0.982) appeared down-regulated in the infected 
SL samples respect to the SL control ones whilst the SDC expression levels were similar between control and infected 
R samples (Fig. 3b).
Discussion
In this work we set up an in vitro system to study the influence of the interaction between bacterial endophytes 
and E. purpurea plants on the production of plant bioactive compounds.
The infection data revealed the bacterial tendency to reach their niche of origin passing through the R appa-
ratus since a significant number of bacteria was detected also in the R tissues of the infected plants. This was in 
agreement with the current literature, according to which one of the ways used by endophytes to reach the aerial 
parts of the host plant was their migration through the xylem vascular system25 once that they have entered the 
Figure 2. Principal Component Analysis of alkamide relative estimations of the four different Echinacea 
purpurea extracts. Letters on vectors indicate the HPLC peaks accounting for the differentiation of samples (see 
text for details). CSL, stem/leaves extract from control plants; ISL, stem/leaves extract from infected plants, CR, 
root extract from control plants; IR: root extract from infected plants.
Figure 3. Gene expression of (a) valine decarboxylase (VDC) and (b) serine decarboxylase (SDC) in control 
and infected samples of Echinacea purpurea plants. Expression levels were normalized to expression in CSL. 
Data report average from three independent experiments (with 3 technical replicates each). Error bars: standard 
error of the mean (s.e.m.). Comparison between infected samples and the relative controls was determined by 
2-tailed t-test (*P < 0.05, **P < 0.01, ***P < 0.001). CSL, stem/leaves extract from control plants; ISL, stem/
leaves extract from infected plants, CR, root extract from control plants; IR: root extract from infected plants.
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plant roots. Hence, we speculated that all the endophytes could reach the SL compartment. However, we were 
not able to consider a post-infection time longer than 45 days since it would have induced several plant damages. 
Therefore, our data confirmed the hypothesis that differences in bacterial strains distribution between R and SL 
of E. purpurea could be related to the physiological conditions existing in the different plant tissues and organs 
representing a specific ecological niche, as previously suggested13.
On the basis of data obtained in this work, the R and SL extracts displayed different alkamide profiles, with 
twelve and ten compounds, respectively identified comparing their HPLC elution orders, ESI-MS/MS, and PDA/
UV spectra with data reported in the literature3,26–29. The most abundant alkamides were the 2,4-diene type com-
pounds and the two isomers dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (7) and dodeca-2E,4E,8Z,10E 
tetraenoic acid isobutylamide (8) being predominant, according to previous studies performed on in vivo 
plants30,31. Moreover, seven alkamides (peaks C, E, F, H, I, J, and M) remained not identified, and among these 
one alkamide (peak F) was present only in the infected SL compartment. To our knowledge, these alkamides were 
not previously reported in E. purpurea.
The estimated total alkamide level was higher in the SL samples than in R ones, apparently in contrast with 
the literature data reporting that the E. purpurea roots contain more alkamides than the leaves2. However, the 
alkamide content in SL samples could be higher than the reported leaves amount since it was the sum of the 
leaves and the vegetative stems. In fact, in line with the literature32, the R and SL extracts were differentiated by 
the presence of the C12 and C11 diene-diyne alkamides (mainly reported in the stem), respectively. On the other 
hand, Qu et al.18 reported that the tetraene alkamides 7 and 8 accounted for the 75% in the aerial part and only 
for the 9% in the roots of E. purpurea plants cultivated into a field and these estimates resulted discordant with 
our results (about 50 and 70%, respectively). To this concern, one possible explanation could be that, to the best 
of our knowledge, this study is the first to estimate the E. purpurea alkamide level in an in vitro model whose 
experimental conditions could influence plant genetics and/or biochemical synthesis. However, the estimated 
alkamide level was higher in both infected R and SL, with a relative increase of alkamides 7 and 8 about 87% and 
70% respectively, when compared to the controls, suggesting that the alkamide biosynthesis was modulated by 
the E. purpurea endophyte infection.
Concerning the VDC gene expression profiles, the highest expression level was detected in the infected E. pur-
purea tissues. By comparing results concerning both the chemical profiling analysis and the VDC gene expression 
data, it could be observed that the use of the proposed in vitro infection model system allowed us to demonstrate 
that the infection of E. purpurea axenic plants with their endophytes influenced the alkamide levels. In fact, 
both alkamide content and VDC transcription level resulted increased after the infection. The transcriptional 
up-regulation in the infected R samples was lower than the expected one: this result could be explained consid-
ering that the increase of the alkamide quantity in the infected R might be due to the transcriptional regulation 
of other enzymes required for the biosynthesis of the alkamide ammine and fatty acid moieties24. Interestingly, 
the SDC enzyme did not seem to contribute to the increase of alkamide levels confirming the specificity of the 
enzymatic source for the amine moiety formation of the alkamides (i.e. the VDC decarboxylase) as reported by 
Rizhsky et al.24.
The main objective of this work was to develop an in vitro model to study the role of the interaction between 
E. purpurea and its endophytes in the modulation of the plant secondary metabolism. Bacterial communities 
differed substantially between E. purpurea organs13 probably exerting a host selectivity able to modulate the com-
munity structure as reported for endophytic fungi33. In fact, the E. purpurea endophytes inoculated in axenic 
plants tended to re-colonize the native niche whose specific properties probably were influenced in turn by the 
natural endophytes. Chemical profiles and VDC genetic expression resulted quantitatively different between the 
control and infected plants, in particular in the SL compartment. Therefore, despite the in vivo status during 
bacterium-host interactions was difficult to mimic in vitro, the infection with E. purpurea SL endophytes modu-
lated the characteristics resulting in axenic conditions, at least to some extent.
Consequently, the whole body of data obtained in this work strongly suggested that the secondary metabolism 
in E. purpurea was influenced by the plant-endophyte interaction thus possibly contributing to the therapeutic 
properties of this medicinal plant.
Materials and Methods
Bacterial cultures and plant material. Bacterial endophytes were isolated from the aerial compartment 
(stem and leaves) of E. purpurea plants grown at the “Il Giardino delle Erbe”, Casola Valsenio, Italy, as previously 
reported13. Stock cultures were grown at 30 °C on tryptone soy agar (TSA; Bio-Rad, USA) solid medium or tryptone 
soy broth (TSB, Bio-Rad, USA) liquid medium. E. purpurea seeds were provided by the “Il Giardino delle Erbe”.
Seed sterilization and plating. Seeds were surface sterilized in order to prevent any unwanted fungal 
or bacterial growth. Seeds were immersed in a 70% (v/v) ethanol for one minute and, subsequently, in a 5% 
sodium hypochlorite solution for eight minutes. They were then rinsed three times with sterile distilled water, 
kept overnight at 4 °C in the dark for growth synchronization and then germinated in De Wit Culture tubes 
(LAB Associates BV, The Netherlands) containing 5 ml of Linsmaier & Skoog Medium (LS) including vitamins 
(Duchefa Biochemie, The Netherlands) at 24 ± 1 °C in the dark. After root formation, the seedlings were trans-
ferred in Wavin flasks (LAB Associates BV, The Netherlands) containing 50 ml of LS solid medium, supplemented 
with 3% sucrose, for a photoperiod of 16 h light a day for a minimum of two months. In order to validate the 
sterility of the obtained model system, cultivable endophyte multiplication into host tissues was checked: both 
shoots and roots were separately collected, washed in saline solution (0,9% NaCl, washing solution), surface 
sterilized in 1% (v/v) hypochlorite for 8 min and rinsed three times with sterile distilled water. Both samples were 
homogenized in saline solution and five replications of 100 μl of the homogenates were plated on TSA medium. 
Bacterial growth was scored after three days of plate incubation at 30 °C.
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Plant infection. Inocula of bacterial endophytes, isolated from SL compartment of E. purpurea plants, were 
incubated for three days at 30 °C in horizontal position and in agitation. The bacterial suspensions were then 
adjusted to 8 × 108 CFU/ml (OD600 = 1). The optical density (OD) was measured in a biophotometer (Eppendorf, 
Germany). The pool generated from 100 μl of each diluted 1:10 OD600 suspension cultures was then centrifuged 
at 4000 rpm for 20 minutes and the pellet suspended in a correspondent volume of 0.9% saline solution. Five 
2-months old E. purpurea plants were infected with 100 μl of bacterial suspension culture. Five plants were used 
as control and were infected with 100 μl of sterilized saline solution. Plants were then incubated in the growth 
chamber at 24 ± 1 °C. After 45 days, SL and R samples from control and infected plants, were collected separately, 
firstly washed in saline solution and then sterilized in 1% (v/v) hypochlorite for 8 min. Then, both tissue samples 
were washed three times with sterile distilled water and separated in different aliquots. R and SL aliquots were 
weighed and dried at 60 °C to be used for n-hexane extract preparation. R and SL aliquots of fresh material were 
ground to a fine powder in liquid nitrogen and successively stored at – 80 °C for RNA extraction. Finally, 1.0 g 
of fresh R and SL tissues were immediately used for the in planta bacterial growth analysis. The experiment was 
performed in triplicate.
In planta bacterial growth analysis. In order to evaluate endophytes multiplication into host tissues, 
1.0 g of each sample was homogenized in saline solution and 100 µl of the homogenate were serially diluted up 
to 10−7/ml cells. Five replications of each dilution were plated on TSA medium. The washing solution and the 
distilled water after the last wash were also diluted to check the presence of bacterial cells on the surface of the 
tissues and the outcome of the sterilization procedure. Bacterial growth was scored after two, three and four days 
of incubation of the plates at 30 °C.
Sample preparation for HPLC analysis of alkamides. Dried and powdered R and SL of control and 
infected E. purpurea plants from three independent experiments were pooled and extracted at room temperature 
with n-hexane (1.0 g of dried drug in 30 ml of solvent for three times, every 24 h) as detailed in Supplementary 
Table 5. Solutions of each n-hexane residue from R and SL samples were then prepared dissolving the respective 
n-hexane extract in an opportune volume of methanol and then centrifuging the mixture. Finally, 20 μl of each 
supernatant solution (2.0 mg/ml) were injected for HPLC-PDA/UV-ESI-MS/MS analysis. The experiment was 
performed in duplicate.
HPLC-PDA/UV-ESI-MS/MS analyses. Qualitative HPLC-PDA/UV-ESI-MS/MS analyses were performed 
using a Surveyor LC pump, a Surveyor autosampler, coupled with a Surveyor PDA detector, and a LCQ Advantage 
ion trap mass spectrometer (ThermoFinnigan) equipped with Xcalibur 3.1 software. Analyses were performed 
using a 4.6 × 250 mm, 4 µm, Synergi Fusion-RP column (Phenomenex). The eluent was a mixture of methanol 
(solvent A) and a 0.1% v/v aqueous solution of formic acid (solvent B). A linear gradient of increasing 55% to 85% 
A was developed within 45 min. The column was successively washed for 15 min with methanol and equilibrated 
with 55% A for 10 min. Elution was performed at a flow rate of 0.8 ml/min with a splitting system of 2:8 to MS 
detector (160 ml/min) and PDA detector (640 ml/min), respectively. The volume of the injected methanol solu-
tions was 20 μl. Analyses were performed with an ESI interface in the positive mode. The ionization conditions 
were optimized and the parameters used were as follows: capillary temperature, 270 °C; capillary voltage, 29.0 V; 
tube lens offset, 50.0 V; sheath gas flow rate, 60.00 arbitrary units; auxiliary gas flow rate, 3.00 arbitrary units; 
spray voltage, 4.50 kV; scan range of m/z 150–1200. N2 was used as the sheath and auxiliary gas. PDA data were 
recorded with 200–600 nm range with preferential channel as the detection wavelength 260 nm.
Quantitative real time PCR (qRT-PCR) analysis. Total RNA from R and SL was extracted from E. purpurea 
tissues using the RNeasy Micro Kit (Qiagen, USA) and quantified by Qubit® 2.0 fluorimeter. One μg of total RNA 
for each sample was reverse-transcribed using the Quantitect Reverse Transcription Kit according to the manufac-
turer’s instructions (Qiagen) including a treatment with 1X gDNA Wipeout Buffer to remove any remaining DNA. 
The relative abundance of the E. purpurea cDNA for BCAA decarboxylases (VDC, GenBank Accession #LT593930; 
SDC, GenBank Accession #LT593931.1) was determined on a QUANTSTUDIO 7 FLEX (Applied Biosystems, USA) 
using the QuantiNova SYBR Green PCR Kit (Qiagen, USA). Ubiquitin E2 genetic expression was used as internal 
reference to normalize mRNA content. The quantification of the expression was measured by the comparative Ct 
(2−∆∆Ct) method34. Target gene expression was relative to the control SL cDNA, which has been adopted as calibrator. 
The experiment was conducted in triplicate. Primer3 software35 was used to design primers specific to SDC template 
(epa_locus_952_iso_8_len_1801_ver_2) as available in the Medicinal Plant Genomics Resource (http://medici-
nalplantgenomics.msu.edu). The primer sequences for the VDC gene were reported in Rizhsky et al.24. All prim-
ers listed in Supplementary Table 2 were synthesized by Eurofins Genomics (Ebersberg, Germany). Independent 
RT-PCR products were sequenced to control for primer specificity.
Statistical analyses. Means and standard deviations of the bacterial TVC data of the three biological rep-
licates were estimated and compared by one-way analysis of variance between R and SL samples. To evaluate 
whether the level estimations of the alkamides (mean peak area values) were useful in reflecting the chemical 
relationships between R and SL samples (controls and infected ones), a PCA was performed36. One-way analysis 
of variance followed by Tukey test was used to compare peak area values between control and infected plants 
and to identify the alkamides mainly responsible of the differences between the samples. Comparison of the 
qRT-PCR data of the three biological replicates was determined by 2-tailed t-test. P < 0.05 was considered signif-
icant (*P < 0.05, **P < 0.01, ***P < 0.001). Error bars are shown as s.e.m. The analyses were performed by using 
the modules present in the PAST program, version 3.1537.
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Data availability. The Authors declare that all the data supporting the findings of this study are available 
within the manuscript and its Supplementary Material and from the Corresponding Author on request.
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